Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Polivy (polatuzumab vedotin) for the Treatment of Diffuse Large B-cell Lymphoma

Drug Name

Polivy™ (polatuzumab vedotin-piiq)

Developer

Genentech

Therapy Class

Antibody-drug conjugate

Product Description

CD79b-directed antibody-drug conjugate

Current Indication

Diffuse large B-cell lymphoma

Market Sector

Oncology

Development Status

Approved in the US
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM
Close
Close
Close

Go Top